EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes

Santosh Basyal iD, Antony D Rawindraraj iD, Rahul Parajuli iD, Shardul Bhattarai iD, Laxman Wagle iD, Kritick Bhandari iD, Vikas Pathak iD

Pulmonary Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/pm/8469617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Medicine, online erschienen am 13.05.2026. Verfasst von Santosh Basyal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal. Hauptthemen laut MEDLINE: Pleural Effusion, Malignant, Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective/Background Pleural fluid cytology remains a cornerstone in diagnosing malignant pleural effusions (MPEs); however, its diagnostic yield varies considerably across cancer subtypes. This study is aimed at evaluating the diagnostic performance of cytology stratified by malignancy type.

Methods

We conducted a retrospective study at a tertiary referral center in Raleigh, North Carolina, enrolling patients aged 18–100 years who underwent thoracentesis for suspected MPE between January 2015 and August 2018. MPE was defined by positive pleural fluid cytology, VATS findings, or histopathological confirmation. Variables analyzed included demographics, cytology results, thoracoscopic findings, and pleural biopsy histopathology.

Results

Of the 779 pleural fluid samples, we included 667 patients (99 malignant and 482 benign); the remaining 86 samples included therapeutic thoracenteses, dry taps, and inadequate volume for cytology. Cytology diagnosed 86 cases of MPE (86.86%), while VATS identified additional eight cases. Overall cytology specificity was 99.8% (95% CI: 99.3%–100%). Adenocarcinoma demonstrated the highest cytologic sensitivity (90.24%), particularly in breast cancer–related MPE (67.44%). Among 482 cytology‐negative cases, 130 had documented cancer histories, most frequently lung cancer (17.69%), hematological malignancies (12.30%), and breast cancer (10.76%). Skin and prostate cancers were more likely to yield false‐negative cytology results. Malignant mesothelioma requires repeat cytology or VATS for definitive diagnosis in most cases.

Conclusion

Pleural fluid cytology is highly specific and most sensitive for lung and breast adenocarcinomas. Combined cytology and VATS demonstrate superior diagnostic accuracy and should be the standard approach when initial cytology is negative and malignancy remains clinically suspected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pleural Effusion, MalignantNeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAged, 80 and overAdultThoracentesisSensitivity and SpecificityAdolescentYoung AdultLung NeoplasmsThoracic Surgery, Video-AssistedNorth Carolina

Stichwörter der Autor:innen

cytologymalignant pleural effusionmedical thoracoscopythoracoscopyvideo-assisted thoracoscopic surgery (VATS)

Autor:innen und Institutionen

  • Department of Internal Medicine, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal.
  • Department of Internal Medicine, University of Missouri, Columbia, Missouri, USA, missouri.edu.
  • Department of Pulmonology and Critical Care, Hospital for Advanced Medicine and Surgery (HAMS), Kathmandu, Nepal.
  • Department of Internal Medicine, Ascension Saint Agnes Hospital, Baltimore, Maryland, USA.
  • Department of Internal Medicine, Kist Medical College Teaching Hospital, Lalitpur, Nepal.
  • Interventional Pulmonology and Critical Care Medicine, Virginia Institute of Lung Diseases, Mechanicsville, Virginia, USA.

ORCID-Profile: Santosh Basyal, Antony D Rawindraraj, Rahul Parajuli, Shardul Bhattarai, Laxman Wagle, Kritick Bhandari, Vikas Pathak

Zitieren

APA

Basyal, S., Rawindraraj, A. D., Parajuli, R., Bhattarai, S., Wagle, L., Bhandari, K., & Pathak, V. (2026). Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes. Pulmonary Medicine, 2026(1). https://doi.org/10.1155/pm/8469617

Vancouver

Basyal S, Rawindraraj AD, Parajuli R, Bhattarai S, Wagle L, Bhandari K, et al. Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes. Pulmonary Medicine. 2026;2026(1). doi:10.1155/pm/8469617

BibTeX
@article{Basyal2026,
  author = {Basyal, Santosh and Rawindraraj, Antony D and Parajuli, Rahul and Bhattarai, Shardul and Wagle, Laxman and Bhandari, Kritick and Pathak, Vikas},
  title = {Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes},
  journal = {Pulmonary Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/pm/8469617}
}
Kostenlos starten →